# FDA Inspection 1193142 - Lewis Drug Inc. - December 15, 2022

Source: https://www.keypedia.com/records/fda_inspections/lewis-drug-inc/fb96db3c-a52e-4209-89e5-65cb4a38cf33
Source feed: FDA_Inspections

> FDA Inspection 1193142 for Lewis Drug Inc. on December 15, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1193142
- Company Name: Lewis Drug Inc.
- Inspection Date: 2022-12-15
- Classification: No Action Indicated (NAI)
- Project Area: Monitoring of Marketed Animal Drugs, Feed, and Devices
- Product Type: Veterinary
- Office Name: Center for Veterinary Medicine

## Related Documents

- [FDA Inspection 1193142 - 2022-12-15](https://www.keypedia.com/records/fda_inspections/lewis-drug-inc/f6672206-5567-45a6-b24b-85d7b1951b85)
- [FDA Inspection 1035432 - 2017-11-29](https://www.keypedia.com/records/fda_inspections/lewis-drug-inc/93ca84eb-4e9a-4ad7-8b13-b7a440bb94db)
- [FDA Inspection 818128 - 2013-02-12](https://www.keypedia.com/records/fda_inspections/lewis-drug-inc/6aef63a6-b8d8-438f-aa9a-04c7c25529f4)

Company: https://www.keypedia.com/companies/lewis-drug-inc/f679ba32-87e6-4adf-a05d-138fefc7db51

Office: https://www.keypedia.com/offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4